Trevor Pugh

Researcher

Related Research

Related News & Events

Research Highlight|May 09, 2023

Scientists find Li-Fraumeni syndrome defined by more than one gene; expansion of genetic and epigenetic testing will benefit patients

Scientists at The Hospital for Sick Children in Toronto find Li-Fraumeni syndrome may be defined by more than one gene, highlighting the benefits of e...

Research Highlight|February 10, 2022

Gut bacteria linked to immune suppression in pancreatic cancer: Study

Lactobacillus – a type of bacteria thought to promote gut health – can alter the function of immune cells called macrophages in the pancreatic tumour ...

Research Highlight|September 10, 2021

New study helps understand who will benefit from immunotherapy

TFRI-funded researchers at the Princess Margaret Cancer Centre in Toronto have made findings which help expand understanding of which patients will be...

Research Highlight|January 08, 2021

Cancer cells hibernate like bears to evade harsh chemotherapy

A team led by Dr. Catherine O’Brien, a TFRI-funded scientist at the Princess Margaret Cancer Centre in Toronto, discovered that when under threat, all...

Research Highlight|August 31, 2020

Repurposing cholesterol drugs to treat multiple myeloma

A new study TFRI-funded researchers at Princess Margaret Cancer Centre found that drugs prescribed to lower blood cholesterol, known as statins, may b...

TFRI News|August 17, 2020

Marathon of Hope Cancer Centres Network operational plan continues to take shape

Plans for implementation of the new pan-Canadian network to accelerate precision medicine continue to move ahead with partners and leaders from the fo...

Research Highlight|August 04, 2020

A blood test could predict who benefits from immunotherapy

A test which detects changing levels of tumour fragments in the blood may be an easy, non-invasive and quick way to predict who will benefit from immu...

Research Highlight|January 15, 2019

Study reveals genomic differences between long- and short- term survivors of high-grade serous ovarian cancer, advancing potential for individualized treatments

Researchers may be one step closer to personalizing treatments for patients with high-grade serous ovarian cancer thanks to a new study that revealed ...

Research Highlight|July 01, 2017

Collaborative generation, sharing and analysis of data could make precision medicine available for patients with colorectal cancer

The TF4CN is allowing scientists in two of Canada’s biggest cancer research centres to work together like never before to tackle four distinct project...

All News & Events